Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM529QO)

Drug Name
pbi-shRNA STMN1 Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Breast cancer 2C60-2C65 Investigative [2]
Cross-matching ID
TTD Drug ID
DM529QO

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
STMN1 messenger RNA (STMN1 mRNA) TT7W5OT STMN1_HUMAN Inhibitor [3]

References

1 ClinicalTrials.gov (NCT01505153) Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced and/or Metastatic Cancer. U.S. National Institutes of Health.
2 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
3 Clinical pipeline report, company report or official report of Gradalis.